Crystal Bridge Announces Receipt by Alpha Cognition of Japanese Patent for Alzheimer Drug Alpha-1062 and Announces Private Placement Updates
- Written by Newsfile
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2020) - Crystal Bridge Enterprises Inc. (TSXV: CRYS.P) ("Crystal Bridge", or the "Company") is pleased to announce that Alpha Cognition Inc. ("ACI"), has received confirmation of a patent being granted in Japan for Alpha 1062 drug being developed for use in the treatment of...